ArticleFrontiers in immunology2022

Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern.

Erika Rudi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.